COVID Symptoms 2026 Are Eerily Similar to a Bad Cold — That’s Exactly the Problem

Being ill in the spring of 2026 causes a certain amount of confusion. You spend a few minutes convincing yourself that it’s allergies, the dry air, or the fact that you were out late when you wake up with a sharp, almost stabbing soreness at the back of your throat that makes swallowing seem insignificant. Then the weariness sets in. You’re sitting on the couch by Wednesday, debating whether or not to take the test.

This is the current appearance of COVID. Not the gasping, dramatic illness of 2020. Something more subtle and subtle, disguised as a severe seasonal cold.

Newer Omicron-lineage variants of COVID-19, which primarily target the upper airways rather than the deep lung tissue seen in the early pandemic, are the main cause of the disease in 2026. As a result, instead of the traditional high fevers and acute dyspnea that characterized previous waves, many infections now manifest as sore throat, congestion, cough, and exhaustion. The virus has, in a way, become more adept at hiding in plain sight, which is a minor but important change. Throughout the first quarter of the year, doctors at urgent care facilities across the nation have frequently observed this pattern.

“Cicada,” officially known as BA.3.2, is currently the most talked-about strain. The strain was given the name “Cicada” because, similar to the cacophonous insect, it surfaced in large quantities after remaining undiscovered for many years. With between 70 and 75 mutations in the spike protein, the portion of the virus that enables it to attach to human cells, BA.3.2 stands out for being extremely genetically divergent. That figure is not insignificant. Even when everything else about the variant appears to be rather mild, it’s the kind of figure that causes virologists to pause and pay attention. According to Johns Hopkins virologist Andrew Pekosz, it appears frightening on paper, but hasn’t yet had disastrous results in the majority of locations. No one seems eager to stop watching it, though.

As of February 11, 2026, BA.3.2 had spread to at least 23 countries, with Denmark, Germany, and the Netherlands accounting for the majority of cases. Through clinical samples and wastewater surveillance, the variant has been found in at least 25 states in the United States since it was initially discovered in June 2025 in a passenger returning from the Netherlands at San Francisco International Airport. Particularly noteworthy is the wastewater data, which frequently reveals the true extent of a variant’s journey long before test results catch up.

BA.3.2’s symptoms are comparable to those of other circulating variants. These include fever, headache, exhaustion, sore throat, cough, congestion, and some gastrointestinal problems like nausea or diarrhea. Although it hasn’t completely vanished, loss of taste and smell, which used to feel like COVID’s hallmark symptom, is now less frequent. This year, sore throats appear to be more common among patients. In contrast to the milder throat irritation observed in earlier waves, the distinct “razor blade” sore throat associated with the NB.1.8.1 Nimbus variant represents a sharper, stabbing sensation. It’s possible that the same trait is present in several current strains; physicians are observing it even outside of the context of the particular Nimbus variant.

The fact that most people’s overall COVID-19 experience has changed is something that is overlooked in variant-by-variant tracking. Current COVID variants often begin more gradually than the flu, which usually strikes like a “ton of bricks” with sudden high fever and body aches. A patient may experience mild congestion on Tuesday, a slight scratchy throat on Monday, and only a genuine “sick” feeling by Wednesday. One reason people put off testing and unintentionally continue to spread it is because of its gradual onset. Whether this slow pattern is a characteristic of particular variants or just the way the virus has adapted to the population following years of widespread immunity is still unknown.

There is no definitive answer to the first question most people ask, which is whether their old vaccine still works. The CDC and World Health Organization have not reported any evidence that the variant causes more severe illness than other circulating strains, despite laboratory studies suggesting decreased antibody neutralization against BA.3.2. Even as researchers continue to examine the effects of this most recent variant, current vaccines are still anticipated to provide protection against serious illness, hospitalization, and death. There is a perception that vaccinations have evolved into a sort of baseline defense rather than a complete shield, sufficient to keep the majority of people out of the hospital but less effective at completely preventing infection.

Then there’s the long-lasting COVID shadow that never truly went away. A 34-year-old former literary agent and university lecturer in Asheville, North Carolina, wakes up every morning so queasy that she can throw up at the smell of food. Before her body cooperates, she stretches for an hour. Every month, she makes the four-hour drive to Chapel Hill for rehabilitation. She contracted the infection in April 2022 and never fully recovered. In a time when the public’s appetite for COVID news has grown dangerously thin, her story isn’t unique; it’s just rarely shared these days. Recently, Dr. Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota, posed the awkward question: how many people are leading compromised lives without understanding why?

As of early March, the test positivity rate was 3.4%, which is below the 5% threshold thought to indicate uncontrolled transmission. XFG is currently the most common variant in the country, accounting for 23% of cases, followed by XFG.1.1 at 21%. That’s stable ground based on the numbers. However, surveillance has been drastically reduced, and public health experts have been open about the implications of this: the numbers we see are most likely underestimating the number of actual infections, especially since home tests are not reported.

Fatigue, coughing, or congestion may persist longer, particularly in older adults, but most people recover from a COVID infection in five to ten days. A doctor’s appointment becomes crucial if symptoms persist for more than a few weeks. This is not to panic, but rather to rule out the kind of post-viral complications that don’t go away on their own. Until your symptoms are generally improving and you have been completely fever-free for at least 24 hours without the use of fever-reducing medication, you are now advised to stay at home and avoid social situations. The strict five-day isolation regulations from a few years ago have loosened, possibly due to public fatigue with limitations as well as scientific advancements.

Covering COVID in 2026 is peculiar because of the emotional register of the entire situation—that is, the fact that it is both a real, ongoing public health concern and something that people around the world have decided to stop fearing. At once, both appear to be true. The virus still exists, continues to evolve, and occasionally robs people of years of their lives. Wearing the face of a persistent cold, it’s just doing it more quietly now. The only true way to know what you’re dealing with is still through testing. At least that part hasn’t changed.